Piramal Pharma Limited will list its shares on Wednesday at a fully paid face value of ₹10 each. Piramal Pharma recently demerged from Piramal Enterprises Limited (PEL) and the demerger plan received the NCLT's approval on August 12. PEL's shareholders have been allotted four shares of Piramal Pharma for every one share in PEL in addition to PEL's existing holding.